Last Price
0.15
Today's Change
0.00 (0.00%)
Day's Change
0.14 - 0.15
Trading Volume
86,354,940
Market Cap
626 Million
Shares Outstanding
4 Billion
Avg Volume
2,759,616
Avg Price (50 Days)
0.12
Avg Price (200 Days)
0.10
PE Ratio
-15.00
EPS
-0.01
Earnings Announcement
27-Feb-2025
Previous Close
0.15
Open
0.15
Day's Range
0.14 - 0.15
Year Range
0.052 - 0.15
Trading Volume
86,354,940
1 Day Change
0.00%
5 Day Change
3.45%
1 Month Change
36.36%
3 Month Change
25.00%
6 Month Change
78.57%
Ytd Change
50.00%
1 Year Change
145.90%
3 Year Change
7.14%
5 Year Change
244.67%
10 Year Change
1037.40%
Max Change
-29.69%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders, including Motor Neurone Disease. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.